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Abstract Article Info 
Introduction: Nasopharyngeal Carcinoma (NPC) is a malignant tumor arising from epithelial cells that cover 
the nasopharynx. NPC is a rare malignancy in children. The incidence of NPC varies by age, geographical and 
ethnic factors which indicate both genetic and environmental factors contribute to the tumor growth. NPC in 
children has several features different from adults.  
Objective: To assess characteristics of nasopharyngeal carcinoma in children and adolescents in dr. Zainoel 
Abidin general hospital Banda Aceh from 2014-2019. 
Methods: The study was conducted in dr. Zainoel Abidin general hospital Banda Aceh. This study is a 
descriptive with cross sectional retrospective design. The data collected from medical records of patients 
diagnosed with nasopharyngeal carcinoma from January 2014-September 2019. The variable including regional 
distribution, gender, age (between 0-25 years), histopathologic types, stage and chemotherapy regimen used. 
The sampling was done by total sampling method. 
Results: The result showed that there was 17 patients of nasopharyngeal carcinoma in children and adolescents 
with the highest case came from Bireuen and North Aceh district 3 (17.7%) patients, respectively. South Aceh 
and West Aceh distric 2 (11.8%) patients, respectively. Nasopharyngeal carcinoma mostly infected 9 (53%) 
male patients than 8 (47%) female with a sex ratio of 1.1 : 1. The age most affected is at the end of childhood 
between 17-25 years were 9 (53%) patients and between 12-16 years were 8 (47%) patients with the average 
age range was 17.2 years (range 13-22 years). Most of histopathologic types found in the type of undifferentiated 
carcinoma (WHO type III) as many as 7 (41.1%) patients with stage IV being the most frequent 9 (53%) patients. 
Most of the histopathologic type found in this study was undifferentiated carcinoma (WHO type III; 41.1%; 
n=7) with stage IV (53%; n=9). The most widely used chemotherapy regimen were combination of Cisplatin 
and Docetaxel with 10 (62.5%) patients. 
Conclusion: Nasopharyngeal carcinoma in children generally occur at the end of childhood with the most 
common histopathological type of undifferentiated carcinoma (WHO type III) and stage IV which associated 
with advanced locoregional disease and higher rates of distant metastasis. 
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1. INTRODUCTION 
Nasopharyngeal carcinoma (NPC) is a tumor arising from the epithelial cells 
that cover the nasopharynx [1]. Multiple factors participate in the etiology of 
NPC including Epstein-Barr virus (EBV) activation, genetic susceptibility and 
exposure to environmental carcinogens. Specifically, risk factors consistently 
associated with NPC in endemic areas include early childhood salted fish 
consumption, preserved foods consumption, lack of fresh fruit or leafy 
vegetables intake, prior chronic respiratory tract conditions, and exposure to 
cooking fumes [2]. The incidence of pediatric NPC varies greatly by age, ethnic 
and geographic factors. The incidence variations of NPC between different 
geographical and ethnic groups indicate that both genetic and environmental 
factors contribute to its growth [3,4,5,6]. Nasopharyngeal carcinoma is a rare 
malignancy in children. Pediatric NPC constitutes 1-5% of all pediatric cancers 
and 20-50% of all primary nasopharyngeal malignant tumors in children [7].  
NPC is relatively common in South China, Southeast Asia, North Africa 
[5,6,8]. According to the International Agency for Research on Cancer (IARC), the 
worldwide crude rate for NPC for 0-14 years old is 0.1/100,000. The most affected 
continent is Asia with 891 cases per year, followed by Africa with 469, America 
with 167, and Europe with 45 cases in 2002 [5]. The annual incidence of NPC in 
the UK is 0.3 per million at age 0-14 years, and 1 to 2 per million at age 15-19 years 
and the incidence was 0.1 to 1.5 per million in the United States [1,9]. 
The incidence of NPC has been observed to occur at two peaks, the ﬁrst 
between 10 and 20 years of age and the second between 40 and 60 years [10]. 
Generally, occurs at the age more than 40 years and rarely occurs in children (<1%). 
The graphic shows that the incidence of NPC in children occurs at the end of 
childhood [3]. Hu et al, found the age range between 9-20 years with an average age 
was 16 years with male sex more common than women by a ratio of 1.63: 1 [6]. 
Mauden et al, found the average age is between 7-16 years, an average of 12 years 
with a male is more at 76% [4]. According to the study of Casanova et al, they found 
that the most frequent age was 16 years ranging from 10-21 years [5]. 
Nasopharyngeal carcinoma in children has several different features from 
adults. Generally, NPC in children tends to be diagnosed at advanced stage but 
has a better prognostic [11]. Generally, NPC in children also has a 
histopathological type of undifferentiated carcinoma that is associated with 
advanced locoregional disease and has a higher rate of distant metastasis and the 
majority of patients who relapse with distal metastases occur during a short 
period of time after treatment. It was said that nasopharyngeal carcinoma in 
children is more closely related to Epstein Barr Virus (EBV) infection [3,4,10]. 
Nasopharyngeal carcinoma in children generally presents with the most 
frequent symptom is cervical lymphadenopathy [9]. Other symptoms such 
as hearing loss/tinnitus, headache, bleeding nose, and nasal obstruction [4]. 
Management of nasopharyngeal carcinoma in children and adolescents 
generally follows the protocol established in adults due to lack of clinical trials in 
the pediatric population [7]. Nasopharyngeal carcinoma in children generally has 
better survival than adults, although it is usually diagnosed at advanced stage but 
has a risk of long-term complications higher length associated with the treatment 
[11]. So that earlier diagnosis will reduce the long-term morbidity of treatment. 
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The aims of this study is to assess the characteristics of nasopharyngeal 
carcinoma in children and adolescents in dr. Zainoel Abidin general hospital 
Banda Aceh Period 2014-2019. 
2. MATERIAL AND METHODS 
This study was a descriptive with cross sectional retrospective design. The 
study was conducted in dr. Zainoel Abidin general hospital Banda Aceh. The data 
collected from medical records of patients diagnosed with nasopharyngeal 
carcinoma in children and adolescents between the ages of 0-25 years with 
undergoing treatment at RSUD Dr. Zainoel Abidin general hospital Banda Aceh 
from 2014-2019. The population was all cases of nasopharyngeal carcinoma in 
children and adolescents based on histopathological examination in the pathology 
anatomic laboratory of RSUD Dr. Zainoel Abidin general hospital Banda Aceh. The 
sampling was done by total sampling method. The data was tabulated and the 
percentage of each dependent variable was calculated and the characteristics of 
nasopharyngeal carcinoma patients were found in the form of a regional 
distribution, gender, age, histopathologic types (used the American Joint Committee 
on Cancer Seventh Edition (AJCC 7) classification), stage (used World Health 
Organisation (WHO) classification) and chemotherapy regimen used. 
3. RESULT 
The researchers identiﬁed 17 patients reported with nasopharyngeal carcinoma 
who were diagnosed at RSUD dr. Zainoel Abidin general hospital Banda Aceh from 
Januari 2014 to September 2019. The number of nasopharyngeal carcinoma cases 
based on regional distribution can be seen in Figure 1. 
Figure 1. Distribution of nasopharyngeal carcinoma based on regional 
distribution 
Based on Figure 1, the most nasopharyngeal carcinoma cases came 
from Bireuen district and North Aceh that is 3 (17.7%) patients, respectively. 
The second area is South Aceh and West Aceh district that is 2 (11.8%) 
patients, respectively. The lowest incidence occurred in Banda Aceh, 
Subulussalam, Singkil, East Aceh, Aceh tamiang, Southwest Aceh and Pidie 
each with 1 (5.9%) patients. 
The highest distribution of nasopharyngeal carcinoma by age was found 
at the end of childhood, between 17-25 years that is 9 (53%) patients and 
12-16 years that is 8 (47%) patients. The most common age is 16 years with 
4 patients and 19 years with 3 patients with an average age was 17.2 years. 
The most common distribution of nasopharyngeal carcinoma by sex was in 
males with 9 (53%) patients compared to females with 8 (47%) patients. The 
number of nasopharyngeal carcinoma cases based on age distribution can be 
seen in Figure 2. 
Figure 2. Distribution of nasopharyngeal carcinoma based on age 
The results showed that the most histopathological type was 
undifferentiated carcinoma (WHO type III) 7 (41.1%) patients, non-
keratinizing squamous cell carcinoma (WHO type II) 6 (35.3%) patients and 
the lowest is keratinizing squamous cell carcinoma (WHO type I) 4 (23.6%) 
patients. Most of the patients had advanced disease with stage IV in 9 (53%) 
patients, stage III in 7 (41.1%) patients and stage II in 1 (5.9%) patient and 
1 patient. In this study, the classification used according to the most recent 
version of the American Joint Committee on Cancer Seventh Edition (AJCC 
7). Most of the patients performed chemotherapy using a combination 
regimen of cisplatin and docetaxel in 10 (62.5%) patients, a combination of 
ifosfamide, cisplatin, uromitexan, paclitaxel in 3 (18.75%) patients, a 
combination of cisplatin, docetaxel and 5-fluorouracil in 2 (12.5%) patients, 
and a combination of cisplatin and 5-fluorouracil in 1 (6.25%) patient. And 
1 new patient was diagnosed with nasopharyngeal carcinoma and had not 
undergone chemotherapy. There were no patients with undergoing 
radiotherapy treatment. 
Table 1. Distribution of nasopharyngeal carcinoma. 
Characteristics   n % 
Male 9 53 % 
Female 8 47 % 
Stage II 1 5.9 % 
Stage III 7 4.1% 
Stage IV 9 53% 
WHO type I (Keratinizing squamous cell carsinoma) 4 23.6 % 
WHO type II (Non-keratinizing squamous cell carsinoma) 6 35.3 % 
WHO type III (Undifferentiated squamous cell carsinoma) 7 41.1 % 
Cisplatin+Docetaxel 10 62.5 % 
Cisplatin+Docetaxel+5-Fluorouracil 2 12.5 % 
Cisplatin+5-Fluorouracil 1 6.25 % 
Ifosfamide+cisplatin+uromitexan+paclitaxel 3 18.75 % 
4. DISCUSSION 
The results showed that nasopharyngeal carcinoma was found 
frequently in Bireun and north Aceh each of 3 (17.8%) patients and in South 
and West Aceh each 2 (11.8%) patients. Majority of these patients have a 
low economic status and lived close to the sea. The high incidence of NPC 
in their district suggested because of the habit of consuming foods 
containing preservatives or marinated related to nitrosamine levels. 
Majority population in Aceh have had habit of consuming salted fish as a 
daily diet. 
The etiology of NPC is multifactorial. Ethnic, environmental and EBV 
seem to play an important role in the causes of NPC [1]. The literature 
explained that genetic and environmental factors contribute to the tumor 
growth [8]. One of the environmental factors is food. High risk foods that 
can develope nasopharyngeal carcinomas such as salted fish, canned food 
and burnt meat. Consuming salted fish is related to carcinogenic compounds 
which nitrosamines contained in salted fish. A case study has found that the 
consumption of salted fish every week before the age of 10 years is 
associated with a threefold increased risk of developing NPC [12]. 
Nasopharyngeal carcinoma in children has a difference from adults, it has a 
close relationship with EBV [11,13]. Detection of nuclear antigens 
associated with Epstein Barr Virus (EBNA) and DNA virus in NPC types II 
and III has revealed that EBV can infect epithelial cells and associated with 
viral transformation [1]. A previous retrospective study found that EBV 
DNA was detected in plasma in about 96% of non-ketarinizing type NPC 
patients compared with only 7% of control patients [1]. Another risk factors 
are smoking, and tobacco [11].. 
Nasopharyngeal carcinoma is a relatively rare malignancy of 
childhood. In our study we found that male is more frequent than female 
with a ratio of 1,1 : 1 with an average age range of 17,2 years (range 13-22 
years). According to study by Kupali et al, they found the incidence of NPC 
was more frequent in male than female with age range of 13 years (7-17 
years) [13]. Study by Yan et al, they also found the highest prevalence of 
NPC was in male as much as 71.4% [11]. Study by Mouden et al, they found 
that males are more frequent than female [4].  
Our study found undifferentiated NPC was the most frequent histological 
type in childhood. Nasopharyngeal carcinoma was diagnosed 
histopathologically based on World Health Organization (WHO) classification 
criteria which has been biopsy in primary tumors [4]. Three subtypes of NPC 
are recognized in the World Health Organisation (WHO) classification, 
keratinizing squamous cell carcinoma (type I), non-keratinizing squamous cell 
carcinoma (type II) and undifferentiated carcinoma (type III) [1]. Most cases 
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in childhood and adolescence based on WHO classification is type III, with a 
few type II cases [1]. Undifferentiated carcinoma is classically associated with 
a more advanced locoregional disease and with more frequent distant 
metastases [4]. Study retrospective found, about 90% children with NPC had 
histopathology type undifferentiated carcinoma with a more aggressive nature 
but had better survival than adults [3,5]. Daoud et al, found that 56.3% patients 
were classified as type III NPC [10]. According to Hu et al, 85 (89.5%) patients 
had type III and 10 patients with type II [6]. The same result by Kupeli et al, 
they found more patients with type III was 96.4% [14]. But according to study 
Mouden et al, they found all patient had subtype histopathological 
undifferentiated carcinoma [4]. The literature, revealed that type II and III has 
associated with the elevation of Epstein-Barr Virus titers, but type I is not [1]. 
This study found that most of the patients were stage IV (n=9; 53%) 
and we found 7 patients classified as stage III (n=7; 41,1%). This is likely 
due to the habit of the children not being aware of their illness or sometimes 
a lack of attention from parents so that most patients came with advanced 
disease. The NPC staging has evolved over the past decades. The 
classification used according to the most recent version of the American 
Joint Committee on Cancer Seventh Edition (AJCC 7) [4]. Study by Mauden 
et al, they found about 12.5% had T1-T2 stages with N0-N1 around 26.6% 
[4]. Other studies found, the most patients with stage IV [5]. According to 
NPC-2003-GPOH/DCOG, more patients with stage III-IV around 99% and 
most of them were undifferentiated [8]. Study by Yan et al, most patients 
with advanced stages were stage III (43.8%) and stage IV (47.0%) [11]. 
Nasopharyngeal carcinoma usually originate from the lateral wall of the 
nasopharynx in the rosen-muller fossa. The tumor can extend within or out 
of the nasopharynx to the contralateral wall and/or postero-superiorly to the 
base of the skull or the palate, nasal cavity or oropharynx [1]. Tumors can 
metastasize to lymph nodes of the neck or metastases to distant organs such 
as bones, lungs, mediastinum, and less frequently to the liver [1]. Cervical 
lymphadenopathy is the initial presentation in many patients [14]. 
Symptoms related to the primary tumor include trismus, pain, otitis media, 
nasal regurgitation due to paresis of the soft palate, hearing loss and cranial 
nerve palsies [1,3,4]. Because of the location of nasopharynx, small tumors 
usually do not cause symptoms and unspecified initial symptoms. Therefore, 
some patients present with advanced stages with distant locoregional 
disease and distant metastases [8,13]. According to a study by Mauden et al, 
they found all of the patients had cervical lymphadenopathy [4]. Study of 
Casanova et al, stated that 6.6% of patients had distant metastases [5]. Study 
of Mauden et al reported that most of the patients with NPC had advanced 
stage T, regional lymph node metastases, and about 2 (3%) patients had 
distant metastases to the lungs, liver and bones [4]. Nasopharyngeal 
carcinoma may extend into the skull base and cause dysfunction of cranial 
nerves VI and XII, resulting in diplopia or dysphonia [15]. 
In this study, the diagnostic tool used to determine the stage were 
Computed Tomography Scanning (CT-Scan) modality with contrast, 
Ultrasonography (USG) and thorax rontgen. Contrast CT or MRI is a modality 
that should be used to assess the extent of local tumour growth and base of 
skull involvement [3]. MRI is more sensitive than CT for detection of the 
primary tumour and the extent of locoregional spread including nodal 
metastasis and perineural extension. CT scan is better than MRI for 
identification of bone erosion. Currently, investigators have recently utilized 
FDG PET alone or combined with CT (FDG PET/CT) to evaluate patients 
with NPC. The advantages of FDG PET can provide semiquantitative 
information about the functional activity of the tumor, detect areas of 
involvement that may overlooked by MRI, distinguish active tumor from scar 
tissue, and evaluate the whole body in a single imaging session. Some studies 
have found that FDG PET or FDG PET/CT can contribute to staging [14]. PET 
scans and PET-CT scans are also used as prognostic tools for NPC [8]. 
In this study most of patients has undergoing chemotherapy, and none 
of them has not undergoing radiotherapy. Most of their parents refuse to be 
referred to hospital that have radiotherapy facilities because of limited 
medical costs so the treatment only limited to chemotherapy. Most of 
patients undergo chemotherapy with combination regimen of Cisplatin and 
Docetaxel were 10 (62,5%) patients and combination of Ifosfamide, 
Cisplatin, Uromitexan, and Paclitaxel were 3 (18,75%) patients. The others 
regimen used were combination of Cisplatin and 5-Fluorouracil and 
combination of Cisplatin, Docetaxel and 5-Fluorouracil. The treatment 
recommendations for childhood NPC usually follow guidelines established 
for adults [6]. The survival beneﬁt was predominantly observed with 
concurrent chemoradiotherapy using platinum-based agents [5,6]. Better 
treatments are needed to improve the cure of advanced or recurrent disease 
and reduce long-term morbidities [9]. Although undifferentiated carcinoma 
is very sensitive to radiation, studies report cure rates range from 30% to 
60% when radiation alone is used. The main problem is high dose radiation 
in children has been linked to significant long-term morbidity. This problem 
causes the involvement of chemotherapy in treatment strategies [3,13].  
The survival of children with NPC has improved over past 4 decades 
with improved RT and chemotherapy. Combined therapy (adjuvant, 
neoadjuvant or concomitant chemotherapy) can significantly improve 
prognosis [9,13]. Based on multicenter study (Nasopharyngeal Carcinoma 
[NPC] 2003 German Society of Pediatric Oncology and 
Hematology/German Children's Oncology Group [NPC-2003-
GPOH/DCOG]), NPC is highly radiosensitive and chemosensitive [8]. In 
recent years, most pediatric patients with NPC have been treated with a 
combination of chemotherapy and radiotherapy with various regimens 
around the world, usually containing Cisplatin and 5-fluorouracil. The 
survival rate is reported vary between 55% and 90% for overall survival 
(OS) and between 60.6% and 77% for disease-free survival (DFS) and 
event-free survival (EFS) [8]. 
According to Cassanova et al, induction chemotherapy before 
radiotherapy was received well in pediatric with NPC. Cisplatin and 5-
fluorouracil are the most commonly used induction chemotherapy. The 
study of Casanova et al, they found that the addition of Docetaxel to the 
Cisplatin and 5-fluorouracil provides a complete response rate after 3 cycles 
which is higher (31%) compared to the cisplatin and 5-fluorouracil regimens 
only (20%) [5].  
Mouden et al, conducted a study using combinations of chemotherapy 
and radiotherapy for NPC patients. All patients were treated with three 
cycles of neoadjuvant chemotherapy every 21 days combining Bleomycine, 
Epirubicin, Cisplatin (BEC) and continued with followed by concurrent 
chemoradiation containing Cisplatin 30 mg/m²/week and radiotherapy (70 
Gy to nasopharynx and the involved nodes and 50 Gy to the remainder 
cervical areas, 2 Gy/fraction in 7 weeks), they found about 78.1% of patients 
with a complete response to therapy [4].  
Radiation is an appropriate therapy for NPC[3]. Retrospective research 
carried out by comparing radiation doses, they found that the radiation dose 
given >60 Gy 5-year disease free survival rate was reached to 70% in T1-
T2 patients compared to only 20% in T3-T4. Retrospective research also 
found that radiation with 50-59Gy gave a 5-year Relapse Free Survival 
(RFS) rate of around 35% compared to 54% at a radiation dose of 70 Gy 
[4]. Evidence shows that RT doses less than 60Gy are proven to reduce 
survival [11]. But the RT doses to the cervical lymph nodes can be reduced 
to 50 Gy or less without affecting survival. A high RT doses is not needed 
for disease control but instead increases the incidence of mortality. Based 
on this evidence, they suggest RT 60-68Gy for primary lesions and 50-60Gy 
for neck lymph nodes [11]. Other opinions also revealed a doses of 50-72 
Gy directed to the primary tumor are recommended for patients older than 
10 years, and a 5-10% reduction in this dose is recommended for children 
younger than 10 years of age [3]. 
Study of Buehrlen et al, after chemotherapy and chemoradiotherapy, the 
treatment was continued with interferon-β (IFN-β) for 6 months. Patients 
received Fiblaferon at a dose of 100,000 IU/kg intravenously over 30 minutes 
3 days per week. The maximum single dose was 5 million IU for patients with 
a body weight >50 kg. IFN-β provides great benefits for the treatment results 
of NPC in children [7]. IFN-β administration can improved survival rates. It is 
known that T-cell immunity to EBV plays an important role in suppressing 
proliferating EBV-infected B cells. Patients with EBV-positive NPC were 
found to have a profound impairment in long term T-cell immunity to EBV. 
This IFN-β inhibits tumor cell angiogenesis. Angiogenesis is essential for 
tumor growth and is a key step for metastasis [8,13]. 
Study by Mouden et al, they found the long-term complications arising 
from the side effects of chemoradiotherapy were trismus (59.4%), hearing 
loss (51.6%), xerostomia (50%), neck fibrosis (37.5%) and radiation 
encephalopathy (4.7%) [4]. Other literature also found complications such 
as endocrine abnormalities, growth disorders, otitis media, mucositis, 
neutropenia, nausea, nephrotoxics, ototoxics undergoing chemotherapy 
and/or radiation [4,8,11]. Side effects that can arise due to interferon 
administration are leukopenia and fever [8,10]. 
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5. CONCLUSION 
Nasopharyngeal carcinoma in children generally have subtype of 
undifferentiated carcinoma with advanced stage, which is stage IV. 
Although the high rate of distant locoregional disease associated with 
undifferentiated carcinoma and NPC in children generally present with 
advanced stages, overall survival is not significantly different from adults 
and survival rates are better than adults. 
Treatment for nasopharyngeal carcinoma in children generally follows 
the guidelines for adults with the results of therapy in children similar to that 
observed in adults, but the long-term toxicity is higher in children. Patients 
with stage I and II have very good survival. Presence of distant metastases 
results in a worse prognosis, despite the administration of combined 
treatment. Early diagnosis and prompt treatment are very important for 
better prognosis. 
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